Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct ...

Huntington’s disease has been successfully treated for the first time using a gene therapy, which may be available in the US ...

A one-time experimental treatment shows unprecedented success in slowing Huntington's disease, according to UCL researchers.

Results from a three-year trial suggest an experimental gene therapy for Huntington's disease can slow the progression of the ...

An experimental gene therapy has slowed the progression of Huntington’s disease by 75 percent, according to results reported ...

In a trial of people with early Huntington's, the newly developed therapy slowed the progression of symptoms by 75%.

A company called uniQure has announced promising results from a trial of a new gene therapy for Huntington’s disease. The ...

Scientists from Tel Aviv University and Boston Children's Hospital use a optimized virus to deliver a corrected gene into the ...

Clinical trials of a groundbreaking new gene therapy for Huntington's disease have shown that it slows progression of the ...

Huntington’s is caused by a single error in our DNA, a “typo” in a gene responsible for creating a protein called huntingtin.

Bucking the trend of IL-12 therapy programme failures, Imunon’s IMNN-001 was bolstered by positive translational data in ...